...
首页> 外文期刊>ACS Omega >Use of BODIPY-Labeled ATP Analogues in the Development and Validation of a Fluorescence Polarization-Based Assay for Screening of Kinase Inhibitors
【24h】

Use of BODIPY-Labeled ATP Analogues in the Development and Validation of a Fluorescence Polarization-Based Assay for Screening of Kinase Inhibitors

机译:使用Bavipy标记的ATP类似物在荧光偏振基测定的开发和验证中用于筛选激酶抑制剂

获取原文
           

摘要

The screening of compound libraries to identify small-molecule modulators of specific biological targets is crucial in the process for the discovery of novel therapeutics and molecular probes. Considering the need for simple single-tool assay technologies with which one could monitor “all” kinases, we developed a fluorescence polarization (FP)-based assay to monitor the binding capabilities of protein kinases to ATP. We used BODIPY ATP-y-S as a probe to measure the shift in the polarization of a light beam when passed through the sample. We were able to optimize the assay using commercial Protein Kinase A (PKA) and H7 efficiently inhibited the binding of the probe when added to the reaction. Furthermore, we were able to employ the assay in a high-throughput fashion and validate the screening of a set of small molecules predicted to dock into the ATP-binding site of PKA. This will be useful to screen larger libraries of compounds that may target protein kinases by blocking ATP binding.
机译:复合文库的筛选以鉴定特异性生物靶标的小分子调节剂是在发现新的治疗和分子探针的过程中至关重要。考虑到需要一种可以监测“所有”激酶的简单单工具测定技术,我们开发了基于荧光极化(FP)的测定,以监测蛋白激酶的结合能力至ATP。我们使用Bodipy ATP-Y-S作为探头,以在通过样品时测量光束偏振的变化。我们能够使用商业蛋白激酶A(PKA)和H7优化测定,当添加到反应时,H7有效地抑制探针的结合。此外,我们能够以高通量的方式使用测定,并验证预测到PKA的ATP结合位点的一组小分子的筛选。这对于通过阻断ATP结合筛选可以靶向蛋白激酶的大型化合物的较大文库是有用的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号